Home

PRODUCT FEATURE

AMR101 is being progressed to Phase 3 development for hypertriglyceridemia, a condition associated with increased levels of heart disease diagnosed in over 10 million people in the US.  Read more..

VIEW OUR PIPELINE

View our Pipeline

LATEST NEWS

31-Jul-2008
Amarin Announces Annual General Meeting Concluded
Full Story
More News »